Your search for major depressive disorder returned 12 results

The new guidelines will facilitate the design and development of clinical trials to test new therapies to minimize the burden of neurologic disability produced by neurosarcoidosis.

Depression is one of the most commonly reported complications resulting from stroke.

There are several drug-based and non-pharmacological treatments available that can help reduce symptoms of depression in patients with epilepsy.

Comorbid psychological conditions affect cognitive function in Parkinson’s disease, and treatment can be complicated by overlapping symptoms.

Neuroimaging and if necessary, genetic testing, can help to confirm an FTD diagnosis.

New findings suggest shared genetic etiology vs causal relationship in comorbid migraine and depression.

A restricted number of surgical procedures are not associated with increased incidence of chronic opioid use.

Medication, plus a relatively sedentary lifestyle, places people with epilepsy at great risk of metabolic syndrome and its various complications.

When first-line therapies fail, physicians must consider several factors when choosing the next course of treatment for their RRMS patients.

Research has shown a confounding link between nicotine and reduced risk of Parkinson’s disease.

Over 60% of people with Parkinson’s disease will have REM sleep behavior disorder, endangering them and their partners during the night.

A multi-faceted approach is best when treating pediatric headache.